Biotech Histogen Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules July 25, 2022
Biotech Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 25, 2022
Biotech Vaxcyte Completes Enrollment of Phase 2 Portion of Phase 1/2 Clinical Proof-of-Concept Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in Adults July 25, 2022
Biotech The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease Community-Based Organizations July 25, 2022
Biotech Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million July 25, 2022
Biotech Agios to Webcast Conference Call of Second Quarter 2022 Financial Results on August 4, 2022 July 25, 2022
Biotech Cocrystal Pharma Reports CC-42344 Pharmacokinetic Data in Influenza A Once-Daily Dosing July 25, 2022
Biotech GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil July 25, 2022
Search
editorial
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
